# A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

> **NCT00611507** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 21 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Oxaliplatin, 5-Fluorouracil

## Key facts

- **NCT ID:** NCT00611507
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2008-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611507, "A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00611507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*